End-of-day quote
Other stock markets
|
||
- | - |
25/04 | Labcorp beats quarterly estimates on strong testing demand | RE |
25/04 | Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln | RE |
Sales 2021 | 460M 0 38.46B | Sales 2022 | 516M 0 43.12B | Capitalization | 452M 0 37.73B |
---|---|---|---|---|---|
Net income 2021 | -379M - -31.65B | Net income 2022 | -3.11B - -259B | EV / Sales 2021 | 8.98 x |
Net Debt 2021 | 679M 0 56.69B | Net Debt 2022 | 1.2B 0 101B | EV / Sales 2022 | 3.21 x |
P/E ratio 2021 |
-8.5
x | P/E ratio 2022 |
-0.14
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.19% |
Latest transcript on InVitae Corp
Managers | Title | Age | Since |
---|---|---|---|
Kenneth Knight
CEO | Chief Executive Officer | 63 | 29/20/29 |
Ana Schrank
DFI | Director of Finance/CFO | - | 02/23/02 |
David Sholehvar
COO | Chief Operating Officer | 56 | 13/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 04/15/04 | |
Randal Scott
CEO | Chief Executive Officer | 66 | 13/10/13 |
Eric Aguiar
BRD | Director/Board Member | 62 | 01/10/01 |
1st Jan change | Capi. | |
---|---|---|
-27.67% | 9.87B | |
-17.30% | 2.74B | |
-11.15% | 2.24B | |
-22.32% | 1.63B | |
+59.69% | 1.39B | |
+23.58% | 771M | |
-1.31% | 760M | |
-28.57% | 516M | |
+5.37% | 310M |